Dr. Siwei Zhou, MD

Dr. Zhou practices at Riverside Medical Center in Riverside, California, part of Kaiser Permanente.

Dr. Zhou's NPI, 1477948412, was assigned on April 6, 2015. Dr. Zhou graduated from University of Pittsburgh School of Medicine in 2015. Dr. Zhou holds California license A161057.

Dr. Zhou's primary practice is Riverside Medical Center, at 10800 Magnolia Avenue, Riverside, CA 92505 in Riverside County. The practice phone is (951) 353-2000.

Dr. Zhou's primary practice is Riverside Medical Center in Riverside, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Zhou to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhou practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Zhou's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Zhou is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Zhou's licenses on file in 3 states: California, Pennsylvania and New Mexico.

Dmand AI lists dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Zhou treats.

CMS data shows 254 Medicare services from Dr. Zhou across 6 procedure codes in 2024, for 131 Medicare patients. Medicare paid $25,625 for them.

CMS counts 131 Medicare patients who saw Dr. Zhou in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zhou's median patient age at 68, with 66% women.

In 2024, Dr. Zhou wrote 236 Medicare Part D claims for 117 patients. 84% of them were for generic drugs. CMS names the drug for 211 of them, across 3 drugs with 11 or more claims each, at $2,873 in total drug cost. In 2023, CMS named 262 claims across 3 drugs.

Dmand AI links 8 papers to Dr. Zhou, published from 2018 to 2022. Dr. Zhou has published most often in Ophthalmic Plast Reconstr Surg. Dr. Zhou's most frequent co-authors are Jacqueline R. Carrasco, MD, Tatyana Milman, MD and Ian P. Conner.

CMS Open Payments shows 26 general payments to Dr. Zhou from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 51% of the total. Valeant Pharmaceuticals International paid the most, $1,631.

Dr. Zhou graduated from University of Pittsburgh School of Medicine in 2015.

Dr. Zhou is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.